Cargando…
Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
BACKGROUND: Patients with nonalcoholic fatty liver disease (NAFLD) are highly at risk for cardiovascular disease (CVD). However, the risk of developing CVD in patients with lean NAFLD is not yet fully understood. Therefore, this study aimed to compare the CVD incidence in Japanese patients with lean...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276489/ https://www.ncbi.nlm.nih.gov/pubmed/37330485 http://dx.doi.org/10.1186/s12876-023-02848-7 |
_version_ | 1785060090146979840 |
---|---|
author | Ishido, Shun Tamaki, Nobuharu Takahashi, Yuka Uchihara, Naoki Suzuki, Keito Tanaka, Yuki Miyamoto, Haruka Yamada, Michiko Matsumoto, Hiroaki Nobusawa, Tsubasa Keitoku, Taisei Takaura, Kenta Tanaka, Shohei Maeyashiki, Chiaki Yasui, Yutaka Tsuchiya, Kaoru Nakanishi, Hiroyuki Kurosaki, Masayuki Izumi, Namiki |
author_facet | Ishido, Shun Tamaki, Nobuharu Takahashi, Yuka Uchihara, Naoki Suzuki, Keito Tanaka, Yuki Miyamoto, Haruka Yamada, Michiko Matsumoto, Hiroaki Nobusawa, Tsubasa Keitoku, Taisei Takaura, Kenta Tanaka, Shohei Maeyashiki, Chiaki Yasui, Yutaka Tsuchiya, Kaoru Nakanishi, Hiroyuki Kurosaki, Masayuki Izumi, Namiki |
author_sort | Ishido, Shun |
collection | PubMed |
description | BACKGROUND: Patients with nonalcoholic fatty liver disease (NAFLD) are highly at risk for cardiovascular disease (CVD). However, the risk of developing CVD in patients with lean NAFLD is not yet fully understood. Therefore, this study aimed to compare the CVD incidence in Japanese patients with lean NAFLD and those with non-lean NAFLD. METHODS: A total of 581 patients with NAFLD (219 with lean and 362 with non-lean NAFLD) were recruited. All patients underwent annual health checkups for at least 3 years, and CVD incidence was investigated during follow-up. The primary end-point was CVD incidence at 3 years. RESULTS: The 3-year new CVD incidence rates in patients with lean and non-lean NAFLD were 2.3% and 3.9%, respectively, and there was no significant difference between two groups (p = 0.3). Multivariable analysis adjusted for age, sex, hypertension, diabetes, and lean NAFLD/non-lean NAFLD revealed that age (every 10 years) as an independent factor associated with CVD incidence with an odds ratio (OR) of 2.0 (95% confidence interval [CI]: 1.3–3.4), whereas lean NAFLD was not associated with CVD incidence (OR: 0.6; 95% CI: 0.2–1.9). CONCLUSIONS: CVD incidence was comparable between patients with lean NAFLD and those with non-lean NAFLD. Therefore, CVD prevention is needed even in patients with lean NAFLD. |
format | Online Article Text |
id | pubmed-10276489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102764892023-06-18 Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease Ishido, Shun Tamaki, Nobuharu Takahashi, Yuka Uchihara, Naoki Suzuki, Keito Tanaka, Yuki Miyamoto, Haruka Yamada, Michiko Matsumoto, Hiroaki Nobusawa, Tsubasa Keitoku, Taisei Takaura, Kenta Tanaka, Shohei Maeyashiki, Chiaki Yasui, Yutaka Tsuchiya, Kaoru Nakanishi, Hiroyuki Kurosaki, Masayuki Izumi, Namiki BMC Gastroenterol Research BACKGROUND: Patients with nonalcoholic fatty liver disease (NAFLD) are highly at risk for cardiovascular disease (CVD). However, the risk of developing CVD in patients with lean NAFLD is not yet fully understood. Therefore, this study aimed to compare the CVD incidence in Japanese patients with lean NAFLD and those with non-lean NAFLD. METHODS: A total of 581 patients with NAFLD (219 with lean and 362 with non-lean NAFLD) were recruited. All patients underwent annual health checkups for at least 3 years, and CVD incidence was investigated during follow-up. The primary end-point was CVD incidence at 3 years. RESULTS: The 3-year new CVD incidence rates in patients with lean and non-lean NAFLD were 2.3% and 3.9%, respectively, and there was no significant difference between two groups (p = 0.3). Multivariable analysis adjusted for age, sex, hypertension, diabetes, and lean NAFLD/non-lean NAFLD revealed that age (every 10 years) as an independent factor associated with CVD incidence with an odds ratio (OR) of 2.0 (95% confidence interval [CI]: 1.3–3.4), whereas lean NAFLD was not associated with CVD incidence (OR: 0.6; 95% CI: 0.2–1.9). CONCLUSIONS: CVD incidence was comparable between patients with lean NAFLD and those with non-lean NAFLD. Therefore, CVD prevention is needed even in patients with lean NAFLD. BioMed Central 2023-06-17 /pmc/articles/PMC10276489/ /pubmed/37330485 http://dx.doi.org/10.1186/s12876-023-02848-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ishido, Shun Tamaki, Nobuharu Takahashi, Yuka Uchihara, Naoki Suzuki, Keito Tanaka, Yuki Miyamoto, Haruka Yamada, Michiko Matsumoto, Hiroaki Nobusawa, Tsubasa Keitoku, Taisei Takaura, Kenta Tanaka, Shohei Maeyashiki, Chiaki Yasui, Yutaka Tsuchiya, Kaoru Nakanishi, Hiroyuki Kurosaki, Masayuki Izumi, Namiki Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease |
title | Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease |
title_full | Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease |
title_fullStr | Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease |
title_full_unstemmed | Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease |
title_short | Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease |
title_sort | risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276489/ https://www.ncbi.nlm.nih.gov/pubmed/37330485 http://dx.doi.org/10.1186/s12876-023-02848-7 |
work_keys_str_mv | AT ishidoshun riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease AT tamakinobuharu riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease AT takahashiyuka riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease AT uchiharanaoki riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease AT suzukikeito riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease AT tanakayuki riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease AT miyamotoharuka riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease AT yamadamichiko riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease AT matsumotohiroaki riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease AT nobusawatsubasa riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease AT keitokutaisei riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease AT takaurakenta riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease AT tanakashohei riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease AT maeyashikichiaki riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease AT yasuiyutaka riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease AT tsuchiyakaoru riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease AT nakanishihiroyuki riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease AT kurosakimasayuki riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease AT izuminamiki riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease |